コンテンツへスキップ
Merck

Should butalbital-containing analgesics be banned? Yes.

Current pain and headache reports (2002-03-02)
William B Young, Hua Chiang Siow
要旨

In the United States analgesic-overuse headache is often caused by butalbital-containing analgesics. These agents can cause physical and psychological dependency, and dangerous withdrawal syndromes. Butalbital-containing analgesics have already been banned in several European countries. They are proven effective in tension-type headache, but not in migraine; there are many alternative treatments for migraine and tension-type headache. In the 20 years since analgesic overuse headache was widely recognized, butalbital overuse has remained distressingly common. It is time to ban these agents.

材料
製品番号
ブランド
製品内容

Supelco
ブタルビタール 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®